Expect us in your inbox every Monday and Thursday. We’ll cover the latest in psychedelic research, cultural insights, and personal narratives surrounding psychedelics—straight from the writers and editors at DoubleBlind.
Before we embark on this psychedelic journey with you, make sure you:
Reply to our welcome email and say hello so we get added to your contacts.
Move us to Primary Inbox (Gmail Users): If you use Gmail, our email might land in the “Promotions” or “Updates” tab:
-
- Drag the welcome email to your “Primary” tab.
-
- When prompted, click “Yes” to ensure all our emails go to your Primary inbox.
Apple Mail Users: Tap on our email address at the top of this email (next to “From:” on mobile) and click “Add to VIPs”
Don’t see us in your inbox at all? Check your spam folder! And if you find us there, mark it as not spam to move us back to your inbox.
🍄 And if you want to live more psychedelically:
Listen to our podcast: The DoubleBlind Magic Hour
Watch us on YouTube
Follow us: Instagram, Facebook, Twitter, and TikTok
DoubleBlind is a trusted resource for news, evidence-based education, and reporting on psychedelics. We work with leading medical professionals, scientific researchers, journalists, mycologists, indigenous stewards, and cultural pioneers. Read about our editorial policy and fact-checking process here.
DoubleBlind Magazine does not encourage or condone any illegal activities, including but not limited to the use of illegal substances. We do not provide mental health, clinical, or medical services. We are not a substitute for medical, psychological, or psychiatric diagnosis, treatment, or advice. If you are in a crisis or if you or any other person may be in danger or experiencing a mental health emergency, immediately call 911 or your local emergency resources. If you are considering suicide, please call 988 to connect with the National Suicide Prevention Lifeline.
